Search filters

Filters
Clear All

Phase

  • 1
  • 2
  • 1
  • 2
  • 9
  • 17
  • 3
  • 18

Found 18 Aging trials

A listing of Aging medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
99 years or below
All genders
The purpose of this study is understand changes in cognition, physical abilities, and quality of life of individuals receiving venetoclax-based chemotherapy.
18 years - 99 years
All genders
The EDIC Study is a follow-up study to the Diabetes Control and Complications Trail ( DCCT) conducted between 1983- 1993. The primary aim of the EDIC Study ( for years 2017-2022) is to examine the prevalence of cognitive, affective, and physical impairments in T1DM, and the association of DCCT treatment …
18 years - 99 years
All genders
This study will measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). Findings from this study lead to a better understanding of factors that influence the course of Alzheimer’s and other diseases of aging. Participation in this study …
75 years - 85 years
Accepts healthy volunteer
All genders
This study investigates the impact of a decision aid on colorectal cancer screening behaviors among older adults with low health literacy. The purpose of this study is to see if a newly developed decision aid pamphlet can influence the screening intentions of adults aged 75-85, who may have different risk …
50 years or above
All genders
Observational
This study investigates the impact of assessing physiologic age in patients newly diagnosed with acute myeloid leukemia (AML) who are 50 years or older. The purpose is to understand how evaluating patients' overall health rather than just their chronological age can affect treatment outcomes such as toxicity, early mortality, remission …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety, tolerability, and anti-tumor activity of an investigational medication in adult patients with solid tumors that express MAGE-A4, a specific tumor-associated antigen. The study focuses on individuals with the HLA-A*02:01 tissue marker, which is necessary for participation.Participants will undergo various study procedures to evaluate the maximum …
18 years or above
All genders
Phase 1
Interventional
This study investigates treatment options for individuals with recurrent or progressive IDH-1 mutant glioma, a type of brain tumor. The purpose is to evaluate the safety and effects of combining an investigational medication with another treatment. Participants will be divided into two phases: a Safety Lead-In phase to determine safe …
18 years - 59 years
All genders
Phase 2
Interventional
This study investigates different treatment approaches for patients with high-risk acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. The study compares the standard treatment of cytarabine and daunorubicin, which are chemotherapy drugs that stop cancer cell growth, with several experimental regimens. These include …
11 - 18 of 18